These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 22688334)

  • 1. Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes.
    Bassi ÊJ; Moraes-Vieira PM; Moreira-Sá CS; Almeida DC; Vieira LM; Cunha CS; Hiyane MI; Basso AS; Pacheco-Silva A; Câmara NO
    Diabetes; 2012 Oct; 61(10):2534-45. PubMed ID: 22688334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes.
    Fiorina P; Jurewicz M; Augello A; Vergani A; Dada S; La Rosa S; Selig M; Godwin J; Law K; Placidi C; Smith RN; Capella C; Rodig S; Adra CN; Atkinson M; Sayegh MH; Abdi R
    J Immunol; 2009 Jul; 183(2):993-1004. PubMed ID: 19561093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice.
    Yaochite JN; Caliari-Oliveira C; de Souza LE; Neto LS; Palma PV; Covas DT; Malmegrim KC; Voltarelli JC; Donadi EA
    Stem Cell Res Ther; 2015 Mar; 6(1):31. PubMed ID: 25884215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infusion with Human Bone Marrow-derived Mesenchymal Stem Cells Improves β-cell Function in Patients and Non-obese Mice with Severe Diabetes.
    Li L; Hui H; Jia X; Zhang J; Liu Y; Xu Q; Zhu D
    Sci Rep; 2016 Dec; 6():37894. PubMed ID: 27905403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet remodeling in female mice with spontaneous autoimmune and streptozotocin-induced diabetes.
    Plesner A; Ten Holder JT; Verchere CB
    PLoS One; 2014; 9(8):e102843. PubMed ID: 25101835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes.
    Zhang W; Ling Q; Wang B; Wang K; Pang J; Lu J; Bi Y; Zhu D
    Stem Cell Res Ther; 2022 Aug; 13(1):406. PubMed ID: 35941696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody combination therapy targeting CD25, CD70 and CD8 reduces islet inflammation and improves glycaemia in diabetic mice.
    Alkhamis T; Barbic J; Crnogorac-Jurcevic T; Greenlaw RE; Peakman M; Jurcevic S
    Clin Exp Immunol; 2012 Nov; 170(2):139-48. PubMed ID: 23039884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.
    Yaochite JN; de Lima KW; Caliari-Oliveira C; Palma PV; Couri CE; Simões BP; Covas DT; Voltarelli JC; Oliveira MC; Donadi EA; Malmegrim KC
    Stem Cell Res Ther; 2016 Jan; 7():14. PubMed ID: 26781648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells.
    Sharma A; Rani R
    Stem Cell Res Ther; 2017 Jul; 8(1):167. PubMed ID: 28701182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells.
    Madec AM; Mallone R; Afonso G; Abou Mrad E; Mesnier A; Eljaafari A; Thivolet C
    Diabetologia; 2009 Jul; 52(7):1391-9. PubMed ID: 19421731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of betatrophin-expressing adipose-derived mesenchymal stem cells induces β-cell proliferation in diabetic mice.
    Sun LL; Liu TJ; Li L; Tang W; Zou JJ; Chen XF; Zheng JY; Jiang BG; Shi YQ
    Int J Mol Med; 2017 Apr; 39(4):936-948. PubMed ID: 28290605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCELL Expression on Murine MSC Licenses Pancreatotropism and Confers Durable Reversal of Autoimmune Diabetes in NOD Mice.
    Abdi R; Moore R; Sakai S; Donnelly CB; Mounayar M; Sackstein R
    Stem Cells; 2015 May; 33(5):1523-31. PubMed ID: 25641589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory and protective effects of adipose tissue-derived mesenchymal stem cells in an allograft islet composite transplantation for experimental autoimmune type 1 diabetes.
    Mohammadi Ayenehdeh J; Niknam B; Rasouli S; Hashemi SM; Rahavi H; Rezaei N; Soleimani M; Liaeiha A; Niknam MH; Tajik N
    Immunol Lett; 2017 Aug; 188():21-31. PubMed ID: 28506774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor.
    Tian L; Gao J; Hao J; Zhang Y; Yi H; O'Brien TD; Sorenson R; Luo J; Guo Z
    Endocrinology; 2010 Jul; 151(7):3049-60. PubMed ID: 20444936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.
    Jalili RB; Zhang Y; Hosseini-Tabatabaei A; Kilani RT; Khosravi Maharlooei M; Li Y; Salimi Elizei S; Warnock GL; Ghahary A
    PLoS One; 2016; 11(1):e0146970. PubMed ID: 26765526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.
    Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG
    Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice.
    Zhao Y; Lin B; Darflinger R; Zhang Y; Holterman MJ; Skidgel RA
    PLoS One; 2009; 4(1):e4226. PubMed ID: 19156219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artesunate prevents type 1 diabetes in NOD mice mainly by inducing protective IL-4-producing T cells and regulatory T cells.
    Li Z; Shi X; Liu J; Shao F; Huang G; Zhou Z; Zheng P
    FASEB J; 2019 Jul; 33(7):8241-8248. PubMed ID: 30916998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human adipose-derived stromal/stem cells protect against STZ-induced hyperglycemia: analysis of hASC-derived paracrine effectors.
    Kono TM; Sims EK; Moss DR; Yamamoto W; Ahn G; Diamond J; Tong X; Day KH; Territo PR; Hanenberg H; Traktuev DO; March KL; Evans-Molina C
    Stem Cells; 2014 Jul; 32(7):1831-42. PubMed ID: 24519994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.